spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Warner Chilcott 

 HSMN NewsFeed - 3 Jun 2019
PTC Therapeutics Promotes Emily Hill to Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2018
Allergan Continues Active Board Refreshment Process
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2016
Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2014
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
Biopharmaceuticals Urology Gastroenterology Personnel
 HSMN NewsFeed - 30 Sep 2013
Amneal Pharmaceuticals to Acquire Four Generic Products
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 9 May 2013
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Feb 2013
Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 May 2012
Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2012
Physio-Control Completes Sale to Bain Capital
Devices Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2011
Elorac, Inc. Promotes Christopher Gabanski as Chief Commercial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 18 Apr 2011
Warner Chilcott Announces Plans to Restructure Western European Operations
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2010
Watson and Richter Announce Exclusive License Agreement for Esmya
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Oct 2010
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2010
Warner Chilcott Announces FDA Approval of Next Generation Actonel
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Sep 2010
Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex(R) Overactive Bladder Treatment for $400 Million in Cash
Biopharmaceuticals Urology Acquisitions
 HSMN NewsFeed - 13 Aug 2010
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Feb 2010
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Jan 2010
Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2009
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
Biopharmaceuticals Urology
 HSMN NewsFeed - 10 Sep 2009
Mission Pharmacal Acquires NataFort(R) and NataChew(TM) Prenatal Prescription Vitamins and Patented Dual Iron Technology from Warner Chilcott
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Aug 2009
Warner Chilcott Acquires P&G's Global Pharmaceuticals Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 May 2009
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 May 2009
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Apr 2009
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 Mar 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Feb 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 31 Jan 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
Biopharmaceuticals Litigation
 HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 18 Jan 2008
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Biopharmaceuticals
 HSMN NewsFeed - 19 Dec 2007
Amarin Announces Management Changes Including Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2007
Avista Capital Partners Agrees to Acquire Bristol-Myers Squibb Medical Imaging for Approximately $525 Million
Biopharmaceuticals Radiology Acquisitions
 HSMN NewsFeed - 13 Dec 2007
Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
Devices Acquisitions
 HSMN NewsFeed - 20 Nov 2007
NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 Oct 2007
Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
Biopharmaceuticals Generics
 HSMN NewsFeed - 26 Oct 2007
Barr's Generic Version of Estrostep(R) Fe Tablets Approved
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Oct 2007
Watson Files Application for Generic FEMCON(R) Fe
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 1 Oct 2007
Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc. for Infringement of FEMCON FE Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Sep 2007
Warner Chilcott Files Lawsuit Against Barr Laboratories, Inc. for Infringement of FEMCON FE Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Aug 2007
Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
Biopharmaceuticals Generics
 HSMN NewsFeed - 7 Dec 2006
First and Only Chewable Birth Control Pill Now Available
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 14 Nov 2006
Warner Chilcott Licenses Worldwide Rights to Schering AG's SEGRA Compound for Dermatologic Indications and Announces Settlement of Yaz(R) Patent Litigation
Biopharmaceuticals Licensing Litigation
 HSMN NewsFeed - 26 Sep 2006
Barr Announces Warner Chilcott Waives Exclusive License for OVCON(R) 35
Biopharmaceuticals Generics
Return to NewsFeed  

 Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 11 additional stories matching:
Warner Chilcott
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!